Cardiovascular health and disease in women

Author affiliations (3)
  • Emory University ROR
  • National Heart Lung and Blood Institute ROR
  • Oregon Health & Science University ROR

The New England Journal of Medicine, 329(4), 247-256, 1993

DOI 10.1056/NEJM199307223290406 PMID 8316269

Abstract

Each year approximately 2.5 million U.S. women are hospitalized for cardiovascular illness, which also claims the lives of 500,000 women annually; half these deaths are due to coronary heart disease1. Despite the magnitude of this problem and its adverse repercussions on the national public health, we have insufficient information about preventive strategies, diagnostic testing, responses to medical and surgical therapies, and other aspects of cardiovascular illness in women. This lack of information is compounded by the less frequent participation of women in research studies; the difference has been due in part to the exclusion of women of childbearing age and in part to the exclusion of elderly women because of their frequent coexisting illnesses2-4. Characteristics of patients and physicians that limit the participation of women in clinical trials and sex-specific psychosocial or economic factors remain largely unexplored.

There is increasing evidence that women undergo intensive or invasive evaluations and treatments for cardiac diseases substantially less frequently than do men with symptoms of similar or lesser severity; this is particularly true for the evaluation of chest pain5-7. The contributions to the differences in the use of procedures of physicians' attitudes toward women patients and their symptoms, different choices made by women themselves, and cultural or social attitudes about sex differences must be assessed, but of pivotal importance is the relation between the use of procedures for women and the clinical outcomes of cardiovascular illness.

In January 1992, the National Heart, Lung, and Blood Institute convened an invitational conference, “Cardiovascular Health and Disease in Women,” to highlight new information derived from epidemiologic and clinical research that was appropriate for clinical application and that required wider dissemination and to identify gaps in contemporary knowledge that impeded the delivery of optimal cardiovascular care to women8. In addition to addressing general issues of the cardiovascular health of women, this article summarizes the recommendations of the conference.

Topics

cardiovascular disease women sex differences diagnosis treatment, coronary heart disease women underdiagnosis gender disparities, Wenger Speroff cardiovascular health disease women review, women cardiovascular risk factors prevention strategies, sex differences cardiac evaluation invasive procedures women, NHLBI conference cardiovascular health women 1992, women clinical trial participation cardiovascular research gaps, coronary heart disease mortality women epidemiology, chest pain evaluation gender bias women cardiac, cardiovascular care women knowledge gaps clinical outcomes
PMID 8316269 8316269 DOI 10.1056/NEJM199307223290406 10.1056/NEJM199307223290406

Cite this article

Wenger, N. K., Speroff, L., & Packard, B. (1993). Cardiovascular health and disease in women. *The New England journal of medicine*, *329*(4), 247-256. https://doi.org/10.1056/NEJM199307223290406

Related articles